The Role of PPARs in Lung Fibrosis
Pulmonary fibrosis is a group of disorders characterized by accumulation of scar tissue in the lung interstitium, resulting in loss of alveolar function, destruction of normal lung architecture, and respiratory distress. Some types of fibrosis respond to corticosteroids, but for many there are no ef...
Main Authors: | Heather F. Lakatos, Thomas H. Thatcher, R. Matthew Kottmann, Tatiana M. Garcia, Richard P. Phipps, Patricia J. Sime |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2007-01-01
|
Series: | PPAR Research |
Online Access: | http://dx.doi.org/10.1155/2007/71323 |
Similar Items
-
Emerging PPARγ-Independent Role of PPARγ Ligands in Lung Diseases
by: Ajit A. Kulkarni, et al.
Published: (2012-01-01) -
The triterpenoid CDDO-Me inhibits bleomycin-induced lung inflammation and fibrosis.
by: Ajit A Kulkarni, et al.
Published: (2013-01-01) -
PPAR-γ ligands repress TGFβ-induced myofibroblast differentiation by targeting the PI3K/Akt pathway: implications for therapy of fibrosis.
by: Ajit A Kulkarni, et al.
Published: (2011-01-01) -
Electrophilic PPARγ Ligands Attenuate IL-1β and Silica-Induced
Inflammatory Mediator Production in Human Lung Fibroblasts via a
PPARγ-Independent Mechanism
by: Christopher M. Hogan, et al.
Published: (2011-01-01) -
Normal Human Lung Epithelial Cells Inhibit Transforming Growth Factor-β Induced Myofibroblast Differentiation via Prostaglandin E2.
by: Amali P Epa, et al.
Published: (2015-01-01)